mRNA Vaccine Production Line Turnkey Solutions

Popular Products

Design-Build Services for Biotechnology Manufacturing Facilities

Media and Buffer Preparation Vessel Manufacturing

Risk-Based Biopharmaceutical Plant and Cleanroom Design

mRNA Vaccine Manufacturing Facility Design-Build

Turnkey Biopharmaceutical Plant Design and Construction

Process-Driven Biopharmaceutical Equipment Integration

Our full-spectrum turnkey production line solutions deliver cGMP-aligned, single-use integrated manufacturing platforms dedicated to end-to-end mRNA vaccine commercialization, covering plasmid DNA upstream synthesis, in vitro transcription (IVT), mRNA purification, microfluidic LNP encapsulation, sterile formulation, aseptic fill-finish and cold-chain compatible finished product handling. Purpose-built for the unique fragility of nucleic acid molecules and stringent regulatory standards for gene-based biotherapeutics, the complete line resolves core industrial bottlenecks including RNA degradation, residual DNA/protein impurities, inconsistent LNP particle size distribution, cross-contamination risks and lengthy validation cycles. Configurable for clinical trial small batches and large-scale mass manufacturing of infectious disease vaccines, oncology mRNA immunotherapies and self-amplifying RNA candidates, the modular turnkey architecture unifies process skids, cleanroom facility layout, automated control systems and QC analytical suites. By integrating all unit operations into a coordinated, audit-ready workflow, the solution shortens project delivery timelines, cuts repeated capital investment and ensures stable batch-to-batch purity, encapsulation efficiency and target mRNA bioactivity for global market registration and commercial supply.

Core Design Philosophy

We adhere to the core design principle of RNA-First Low-Shear Protection, Single-Use Closed Containment, and Regulatory Platform Scalability, engineering every equipment module and spatial layout to match the ultra-sensitive characteristics of mRNA production while supporting rapid product switching and capacity expansion. The design addresses specialized pain points unique to nucleic acid manufacturing that conventional bioprocess lines cannot resolve.

Low-Shear Nucleic Acid Preservation Architecture: Optimize flow channel geometry, stirring speed and microfluidic mixing shear force across IVT reactors, TFF systems and LNP formulation skids to prevent mRNA strand breakage, aggregation and degradation, maximizing final product recovery rate.

Single-Use Full Closed Containment Workflow: Deploy fully disposable fluid contact assemblies for all core process steps, eliminating cross-batch carryover risks and removing reliance on complex CIP/SIP validation; independent segregated zones block RNase and microbial intrusion throughout the whole production cycle.

Precision LNP Formulation Control Logic: Equip proprietary microfluidic mixing modules with real-time flow ratio, temperature and pH closed-loop regulation to achieve uniform nanoparticle size, consistent encapsulation efficiency and low batch variability for mRNA-lipid complexes.

Modular Expandable Platform Layout: Standardized plug-and-play skid frames and reserved utility interfaces support flexible capacity scaling, additional chromatography units and multi-product campaign switching without full facility reconstruction, adapting to evolving vaccine pipelines.

Authoritative Global Compliance System

All line hardware, process control software, single-use material specifications and facility zoning fully comply with FDA, EMA mRNA vaccine quality guidelines, ICH and ISPE biopharmaceutical engineering norms, meeting rigorous CMC documentation and cross-border audit requirements for nucleic acid therapeuticsEuropean M…. Complete validation dossiers and risk assessment reports are delivered to streamline IND filing, factory qualification and batch release procedures.

Nucleic Acid-Specific GMP Standards Compliance: Fully aligned with dedicated EMA/FDA guidance for mRNA manufacturing, implementing strict controls over residual plasmid DNA, dsRNA, endotoxins and process reagents; all wetted materials feature ultra-low nucleic acid adsorption and RNase-free certification.

Full Lifecycle Data Integrity Framework: Centralized automation system built to satisfy 21 CFR Part 11 requirements, capturing real-time parameters for IVT reaction, chromatography elution, LNP mixing and filling operations with immutable, retrievable audit trails for full batch traceability.

Cross-Regional Market Adaptability: Process design and equipment documentation accommodate regional regulatory variances for gene-based vaccines, supporting registration and commercial production across North America, EU, Asia and emerging biomanufacturing markets.

Full-Scope Turnkey Engineering & Delivery Services

We provide one-stop full-lifecycle integrated services covering process consulting, customized line configuration, facility layout design, equipment manufacturing, on-site integration, commissioning and post-delivery compliance technical support, realizing seamless handover of fully operational mRNA vaccine production bases.

Process Customization & Flow Scheme Design: Conduct process feasibility trials according to client vaccine molecular characteristics and target annual output, outputting tailored line layout, equipment sizing and single-use consumable matching solutions for pDNA, mRNA DS and mRNA-LNP DP workflowsThermo Fis….

Integrated Skid Manufacturing & Cleanroom Matching: Deliver pre-assembled turnkey skids including plasmid fermentation systems, IVT reactors, mRNA purification chromatography/TFF units, microfluidic LNP formulation platforms and robotic aseptic filling lines, paired with dedicated Grade A/B classified cleanroom layout optimization.

Intelligent Centralized Automation Deployment: Integrate unified process control, real-time particle/LNP parameter monitoring, abnormal interlock alarm and remote data management systems to realize standardized, low-manpower unmanned production.

Validation Documentation & Long-Term Technical Backing: Supply complete equipment qualification protocols, process validation master plans, analytical method transfer packages and SOP manuals, with ongoing technical support for process optimization, capacity expansion, new vaccine campaign conversion and regulatory inspection preparation.